Michal Sebastian Marzecki

Genegoggle Sp zoo is an innovative biotech company based in Warsaw, Poland. The Polish company offers platform-centric solutions to the challenges of precision medicine and contributes to the realization of the future of health. Genegoggle aims to develop selective delivery systems that target specific types of cells through its disruptive approach and AI-powered tools for designing next-generation compounds. The company systematically analyzes the 3D structure of DNA, identifies epigenetic modifications and mutations, compares healthy and pathological cells, measures parameters between genomic regions of interest, and understands the current state of the chromatin. Genegoggle was founded by Michal Sebastian Marzecki, Marcin Kruczyk, Jakub Mieczkowski, and Jakub Mieczkowski has been the CEO since incorporation.

Genegoggle Sp zoo is an innovative biotech company based in Warsaw, Poland. The Polish company offers platform-centric solutions to the challenges of precision medicine and contributes to the realization of the future of health. Genegoggle aims to develop selective delivery systems that target specific types of cells through its disruptive approach and AI-powered tools for designing next-generation compounds. The company systematically analyzes the 3D structure of DNA, identifies epigenetic modifications and mutations, compares healthy and pathological cells, measures parameters between genomic regions of interest, and understands the current state of the chromatin. Genegoggle was founded by Michal Sebastian Marzecki, Marcin Kruczyk, Jakub Mieczkowski, and Jakub Mieczkowski has been the CEO since incorporation.